Jonathan C. Javitt, Director, 10% Owner at NRX Pharmaceuticals, Inc. (NRXP), sold 400,000 shares at $1.00 ($400K) on 2022-12-07, disclosed to the SEC on 2022-12-09.
Open-market sale of $400k NRXP by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NRXP | BUY | 2023-08-23 | $64K | — | Filing → |
| NRXP | BUY | 2022-06-02 | $5.8M | — | Filing → |
| NRXP | BUY | 2022-06-02 | $116K | — | Filing → |